Scarica l'app Stockscreener
6.60
0.92%
0.06
Dopo l'orario di chiusura:
6.60
Precedente Chiudi:
$6.54
Aprire:
$6.535
Volume 24 ore:
9,451
Relative Volume:
0.43
Capitalizzazione di mercato:
$110.78M
Reddito:
$22.43M
Utile/perdita netta:
$-17.19M
Rapporto P/E:
-4.9669
EPS:
-1.3288
Flusso di cassa netto:
$-10.02M
1 W Prestazione:
+3.23%
1M Prestazione:
+11.86%
6M Prestazione:
+12.82%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$6.40
$6.60
Intervallo di 1 settimana:
$6.34
$6.79
Portata 52W:
$4.7237
$6.99
Bioharvest Sciences Inc Stock (BHST) Company Profile
Nome
Bioharvest Sciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BHST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
6.60 | 110.78M | 22.43M | -17.19M | -10.02M | -1.3288 |
|
KHC
Kraft Heinz Co
|
27.17 | 33.41B | 25.43B | 2.66B | 3.03B | 2.19 |
|
GIS
General Mills Inc
|
53.28 | 29.81B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
81.80 | 28.64B | 12.63B | 1.38B | 863.00M | 3.96 |
|
MKC
Mccormick Co Inc
|
73.56 | 20.10B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.16 | 16.01B | 11.91B | 756.75M | 890.57M | 1.37 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-05 | Iniziato | Craig Hallum | Buy |
| 2024-12-18 | Iniziato | Maxim Group | Buy |
Bioharvest Sciences Inc Borsa (BHST) Ultime notizie
BioHarvest Sciences advances CDMO pharma deal to Stage 2, eyes scaled compound production - Proactive Investors
Small cap wrap: TNR Gold, BioHarvest, Arizona Gold & Silver, Zynex... - Proactive financial news
BioHarvest Announces Completion of Stage 1 Development for CDMO - GuruFocus
BioHarvest Advances CDMO Contract, Validates Botanical Synthesis Platform - TipRanks
BioHarvest Sciences advances CDMO project with Nasdaq-listed pharmaceutical company to next stage - Proactive financial news
BioHarvest Sciences Inc. Announces CDMO Contract - marketscreener.com
BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company - Newsfile
BioHarvest Sciences Inc. (BHST) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
BioHarvest Sciences (BHST) to Release Earnings on Thursday - Defense World
BioHarvest Sciences (NASDAQ:BHST) Now Covered by Craig Hallum - Defense World
BioHarvest stock gains on new Buy rating, $15 target from Craig-Hallum - Investing.com UK
Craig-Hallum Recommends BioHarvest Sciences (BHST) with Strong Buy Rating | BHST Stock News - GuruFocus
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time | BHST Stock News - GuruFocus
BioHarvest Sciences to Announce Q1 2025 Financial Results - TipRanks
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time - TradingView
BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock? - MSN
Analysts Set Expectations for BHST Q1 Earnings - Defense World
Research Analysts Set Expectations for BHST Q2 Earnings - The AM Reporter
What is HC Wainwright’s Estimate for BHST Q2 Earnings? - Defense World
BioHarvest Sciences’ (BHST) Buy Rating Reaffirmed at HC Wainwright - Defense World
H.C. Wainwright maintains BioHarvest stock Buy rating, $14 target - Investing.com Australia
H.C. Wainwright maintains BioHarvest stock Buy rating, $14 target By Investing.com - Investing.com Canada
Here's Why BioHarvest Sciences (NASDAQ:BHST) Can Afford Some Debt - simplywall.st
Q1 Earnings Forecast for BHST Issued By Diamond Equity - Defense World
BioHarvest Sciences Reports Strong Revenue Growth and Strategic Expansion - TipRanks
BioHarvest Sciences Reports Strong Growth Amid Challenges - TipRanks
BioHarvest CEO talks Nasdaq uplisting, profit targetsICYMI - Proactive financial news
BioHarvest Sciences Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
BioHarvest shares rise after Q4 results show strong demand for VINIA products - Proactive financial news
Small cap wrap: Ideal Power, Voyageur Pharmaceuticals, North Bay Resources, Trust Stamp... - Proactive financial news
BioHarvest Sciences reports record-breaking 2024 revenue and expansion milestones - Proactive financial news
BioHarvest Sciences Inc (BHST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo
BioHarvest Sciences Inc (BHST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates - MSN
BioHarvest Sciences Reports Strong Financial Growth and Strategic Partnership - TipRanks
BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results - Newsfile
Contrasting CureVac (NASDAQ:CVAC) & BioHarvest Sciences (NASDAQ:BHST) - The AM Reporter
BioHarvest Sciences (BHST) to Release Earnings on Monday - Defense World
Ilan Sobel, CEO of BioHarvest Sciences - iHeart
Strength Seen in BioHarvest Sciences Inc. (BHST): Can Its 12.7% Jump Turn into More Strength? - Nasdaq
BioHarvest Sciences to Announce Q4 and Full Year 2024 Financial Results - TipRanks
BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time - Newsfile
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD - Newsfile
BIOHARVEST SCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025 - Newsfile
Bioharvest Sciences Inc Azioni (BHST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):